RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Greg Gojanovich to Immunotherapy

Back to Details
This is a "connection" page, showing publications Greg Gojanovich has written about Immunotherapy.
Greg Gojanovich
Connection Strength
0.414
Immunotherapy
  1. Gojanovich GS, Murray SL, Buntzman AS, Young EF, Vincent BG, Hess PR. The use of peptide-major-histocompatibility-complex multimers in type 1 diabetes mellitus. J Diabetes Sci Technol. 2012 May 01; 6(3):515-24.
    View in: PubMed
    Score: 0.385
  2. Maurice Morillon Y, Martin A, Gojanovich G, Wang B, Tisch R. Reestablishing T Cell Tolerance by Antibody-Based Therapy in Type 1 Diabetes. Arch Immunol Ther Exp (Warsz). 2015 Aug; 63(4):239-50.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support